Partner With Us NRI

Narayana Hrudayalaya Ltd share Price Today

Company details

6M Return 37.14%
1Y Return 64.98%
Mkt Cap.(Cr) 25,040.35
Volume 392,970
Div Yield 0.20%
OI Chg %
Volume 392,970

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500
Steady quarter amid seasonality; focus on new capex
About The Stock

    NHL operates a chain of multispecialty, tertiary & primary healthcare facilities that initially focused on cardiac & renal but expanded to cancer, neurology, neurosurgery, orthopaedics & gastroenterology facilities.

    • NHL’s network comprises 21 hospitals (including two managed hospitals), four       heart centres, 18 primary care facilities (including clinics and information centres) and a multi-speciality hospital in Cayman Islands)
    • Revenue mix FY22 – India: ₹ 2965.5 crore; (Bangalore:31%, Southern Peripheral:7%, Kolkata:27%, Eastern Peripheral: 5%, Western: 16%, Northern: 13%); Cayman Islands: US$91.9 million

    NHL reported in line numbers amid Omicron wave and subsequent recovery in India business in March aided by traction in Caymans.

    • Revenues were up 12.3% YoY to ₹ 940.7 crore
    • EBITDA was at ₹ 175.1 crore, up 23.8% YoY with margins at 18.6%
    • Adjusted PAT was at ₹ 68.9 crore (up 1.3% YoY)

Click here for full recommendation

Research view on more stocks

Healthcare facilities company Narayana Hrudayalaya announced consolidated Q1FY24 results:

  • Total operating income was Rs 12,334 million for Q1FY24 as compared to Rs 10,334 million in Q1FY23, reflecting an increase of 19.4% YoY and 1.0% QoQ.
  • EBITDA stood at Rs 2,858 million, reflecting a margin of 23.2% as against Rs 2,000 million in Q1FY23, translating into YoY growth of 42.9% and a decrease of 1.6% QoQ.
  • PAT stood at Rs 1,840 million, reflecting a margin of 14.92% as compared to Rs 1,106 million in Q1FY23, translating into YoY growth of 66.4% and QoQ growth of 6.2% respectively.
  • India's operating income was Rs 9,897 million for Q1FY24 as compared to Rs 8,654 million in Q1FY23, reflecting an increase of 14.36% YoY and 0.6% QoQ.
  • HCCL operating income was Rs 2,551 million for Q1FY24 as compared to Rs 1,755 million in Q1FY23, reflecting an increase of 45.4% YoY and 4.3% QoQ.
  • As on June 30, 2023, the Total Borrowings less Cash, Bank Balance, and Current Investments were Rs 188 million representing a net debt-to-equity ratio of 0.01.

Commenting on the performance, Dr. Emmanuel Rupert, Managing Director and Group CEO, Narayana Hrudayalaya, said, “The first quarter of the new fiscal year has started with a robust performance. We are pleased to report the highest-ever revenue every quarter with profitability sustaining at high levels. The international patient mix remains flat, and the payor mix and speciality mix is in line with the last quarter of the previous fiscal year. Our overseas business in Cayman continues to contribute to overall performance, achieving the highest-ever revenue and profitability every quarter, which is attributed to increased patient footfalls.

Our newly incorporated company Narayana Health Integrated Care (NHIC) has started on a positive note, and we are confident that it will have a significant impact on our overall business in the future.”



Result PDF

View Other Company Results


Investment recommendation
Steady quarter amid seasonality; focus on new capex
Call Date
11 Feb 2023
Entry Price 717.00
Target Price 870.00
12-18 Month


Operating Profit
Profit after Tax
Reserves and Surplus
Operating Profit
Profit after Tax

Narayana Hrudayalaya Ltd Stocks COMPARISION


Equity Capital: 2,132.67 Cr FV: 10.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 15,779.50 22,156.90
LAST 3M 54,802.13 -2,099.03
LAST 6M 93,089.45 78,838.27
LAST 12M 161,092.98 118,023.38

Narayana Hrudayalaya Ltd Information

Stock PE (TTM)
Promoter Holding
Book Value
  • Narayana Hrudayalaya runs a chain of multi-speciality hospitals located across India. The company also operates primary care facilities, heart centres, and other healthcare facilities. The company has its headquarters in Bengaluru. Narayana Health was started by Dr Devi Shetty in 2000. As on 19 December 2022,  the company employs more than 11,000 professionals a year.

    On 19 December 2022, the market capitalisation of the company was Rs 15,434.35 crore. It reported consolidated sales of Rs 746.55 crore at the end of September 2022. The company is listed on the Bombay Stock Exchange with the code 539551 and the National Stock Exchange with the code NH.

    The promoters of Narayana Health currently hold approximately 63.85% of the company. The foreign institutional investors’ investment in the company amounts to 14.16%. Various mutual funds hold around 13.43% of the company. The total public stake in the company is approximately 8.3%. The stake of the public has grown steadily over the past year (Since September 2021).

    Dr Devi Prasad Shetty is the chairman of the company and a whole-time director, and Emmanuel Rupert is the CEO and managing director. Viren Prasad Shetty, Kiran Mazumdar Shaw, Arun Seth, Dinesh Krishnaswamy, and TS Bresenham are the other directors of the company. Deloitte, Haskins, & Sells LLP are the auditors of Narayana Health. As of December 2022, the company had around 20.4 crore shares outstanding.

    On 19 December 2022, Narayana Health’s share price on NSE was Rs 754.2 and Rs 753.3 on BSE. The share price touched a 52-week high of Rs 810.5 and a 52-week low of Rs 545.1. Its three-month return to investors was 8.64%, while its one-year return was 32.54%. The company’s total operating income grew 12.3% quarter-on-quarter during the fourth quarter of FY22.

    As of November 2022, Axis Small Cap Direct-G has invested Rs 501.1 crore in the company. Other prominent mutual funds with investments in Naryana include SBI Small Cap Direct-G, with an investment of Rs 266.8 crore, and Nippon India Pharma Direct-G, with an investment of Rs 221.4 crore in the company.

    Some of Narayana's peers include Max Healthcare, Fortis Healthcare, and Krishna Institute of Medicine.

    Disclaimer: ICICI Securities Ltd. (I-Sec). Registered office of I-Sec is at ICICI Securities Ltd. - ICICI Venture House, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025, India, Tel No : 022 - 6807 7100. I-Sec is a Member of National Stock Exchange of India Ltd (Member Code: 07730), BSE Ltd (Member Code: 103) and Member of Multi Commodity Exchange of India Ltd.(Member Code: 56250) and having SEBI registration no. INZ000183631. Name of the Compliance officer (broking): Ms. Mamta Shetty, Contact number: 022-40701022, E-mail address: complianceofficer@icicisecurities.com. Investments in securities market are subject to market risks, read all the related documents carefully before investing. The contents herein above shall not be considered as an invitation or persuasion to trade or invest. I-Sec and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. Such representations are not indicative of future results. The securities quoted are exemplary and are not recommendatory. Investors should consult their financial advisers if in doubt about whether the product is suitable for them. The contents herein above are solely for informational purpose and may not be used or considered as an offer document or solicitation of offer to buy or sell or subscribe for securities or other financial instruments or any other product. Investors should consult their financial advisers whether the product is suitable for them before taking any decision. The contents herein mentioned are solely for informational and educational purpose.

Registered Address

No 258/A Bommasandra Indl Area, Anekal Taluq, Bengaluru, Karnataka, 560099

Tel : 91-80-71222802
Email : investorrelations:narayanahealth.org
Website : http://www.narayanahealth.org

KFin Techologies Ltd

AGM Date (Month) : Aug
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 539551
NSE Code : NH
Book Closure Date (Month) :
BSE Group : A
ISIN : INE410P01011

FAQ’s on Narayana Hrudayalaya Ltd Shares

You can buy Narayana Hrudayalaya Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Narayana Hrudayalaya Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Dec 01, 2023 03:59 PM the closing price of Narayana Hrudayalaya Ltd was ₹ 1,225.30.

Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Dec 01, 2023 03:59 PM, the market cap of Narayana Hrudayalaya Ltd stood at ₹ 25,040.35.

The latest PE ratio of Narayana Hrudayalaya Ltd as of Dec 01, 2023 03:59 PM is 33.88

The latest PB ratio of Narayana Hrudayalaya Ltd as of Dec 01, 2023 03:59 PM is 0.10

The 52-week high of Narayana Hrudayalaya Ltd is ₹ 1,314.10 while the 52-week low is ₹ 705.10

According to analyst recommendations, Narayana Hrudayalaya Ltd has a “Buy” rating for the long term.

Download Our App

market app
market app